Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sexual dysfunction
ICD-10 F13.981 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sexual dysfunction.
F13.981 refers to a condition characterized by the use of sedative, hypnotic, or anxiolytic substances that leads to sexual dysfunction. This code is used when the specific substance is not identified, but the patient exhibits symptoms of sexual dysfunction as a result of their substance use. Sedative, hypnotic, and anxiolytic medications are commonly prescribed for anxiety, insomnia, and other related disorders. However, prolonged use can lead to dependence and withdrawal symptoms, which may include sexual dysfunction. This dysfunction can manifest as decreased libido, erectile dysfunction, or other sexual performance issues. The diagnosis requires careful assessment of the patient's substance use history, current medications, and sexual health. Treatment may involve a combination of substance use disorder interventions, psychotherapy, and possibly medication adjustments to address both the addiction and the sexual dysfunction. Accurate coding is essential for appropriate treatment planning and insurance reimbursement.
Detailed patient history, including substance use and sexual health assessments.
Patients presenting with anxiety disorders and sexual dysfunction related to medication use.
Consideration of alternative therapies and monitoring for withdrawal symptoms.
Assessment of sexual function and detailed history of medication use.
Men experiencing erectile dysfunction linked to sedative use.
Coordination with mental health providers for comprehensive care.
Used when managing a patient with substance use disorder and associated sexual dysfunction.
Document the patient's history, examination findings, and treatment plan.
Psychiatric evaluations may require additional documentation of mental health status.
F13.981 is significant as it captures the intersection of substance use and sexual dysfunction, allowing for targeted treatment and better understanding of the patient's overall health.
